North American autotransfusion system market Size to Reach US$ 549.78 million by 2033 - Exclusive Report by DataM Intelligence

The North American autotransfusion system market was valued at US$ 286.52 million in 2024 and is projected to reach US$ 549.78 million by 2033, expanding at a CAGR of 7.6% during the forecast period 2025-2033.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/north-america-autotransfusion-system-market?sg

Mergers & acquisitions (2025):

✅ Haemonetics → sale of whole-blood assets to GVS S.p.A. - Haemonetics completed the divestiture of certain whole-blood business/assets to Italian firm GVS; transaction closed in January 2025 and included upfront cash plus contingent consideration. This affects supply/ownership of some consumables and related product lines that are used alongside autotransfusion/cell-salvage workflows.

✅ Medtronic continuing to promote/expand the autoLog IQ autotransfusion platform.
Medtronic's autoLog IQ remains an actively promoted, FDA-cleared autotransfusion product with Dynamic Cell Salvage features; Medtronic materials in 2025 emphasize its washout performance and use across specialties (cardiac, ortho, trauma).

✅ Haemonetics' Cell Saver® Elite®+ still a market mainstay with ongoing product/firm activity in 2025.
Haemonetics continues to position the Cell Saver Elite+ as a go-to autologous blood recovery system; company communications and product pages in 2025 keep this device in focus for hospitals managing medium-to-high blood-loss procedures.

✅ LivaNova's Xtra autotransfusion system remains listed among current cardiopulmonary product offerings.
LivaNova continues to list the XtraTM autotransfusion system as part of its cardiopulmonary portfolio (product pages remain live in 2025).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=north-america-autotransfusion-system-market

Market Drivers:

➠ Rising Surgical Procedures
The increasing prevalence of cardiovascular disorders, orthopedic complications, and trauma injuries has led to a higher number of surgical interventions. Autotransfusion systems are increasingly being used to reduce dependency on donor blood during these procedures.

➠ Concerns Over Blood Safety
Growing risks associated with blood-borne infections, limited donor blood availability, and rising costs of blood transfusion have boosted the demand for autotransfusion systems, which provide patients with their own salvaged blood.

➠ Technological Advancements
Continuous improvements in device efficiency, portability, and automation have made autotransfusion systems more reliable and user-friendly. This has encouraged hospitals and surgical centers to expand their adoption across different surgical departments.

➠ Focus on Cost-Effectiveness
With increasing healthcare expenditure, hospitals are prioritizing methods that lower overall treatment costs. Autotransfusion minimizes the need for donor blood, reducing both direct and indirect costs associated with blood procurement and storage.

➠ Growing Awareness and Training Programs
Educational initiatives by hospitals and professional organizations are improving awareness among clinicians about the clinical and economic benefits of autotransfusion systems, further supporting their penetration in North America.

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Market Segments:
By Product Type (Intraoperative Autotransfusion Systems, Postoperative Autotransfusion Systems, Dual-Mode Autotransfusion Systems, Autotransfusion Accessories)
By Technique (Perioperative cell salvage (PCS), Acute normovolaemic Haemodilution (ANH), Predeposit autologous donation (PAD))
By Application (Orthopedic, Neurology, Cardiology, Others)
By End User (Hospitals, Specialty Clinics, Others)

Market Geographical Share

The North American region accounts for a significant share of the global autotransfusion system market, driven primarily by the strong presence of advanced healthcare infrastructure, high surgical volumes, and growing adoption of blood management technologies.

United States dominates the regional market, owing to a well-established hospital network, high rate of complex surgeries such as cardiac, orthopedic, and trauma-related procedures, and supportive reimbursement structures. Increasing awareness among clinicians regarding the benefits of intraoperative and postoperative blood salvage has further strengthened adoption.

Canada is witnessing steady growth due to a rising geriatric population, expanding surgical procedures, and growing emphasis on reducing allogeneic blood transfusion risks. The country's healthcare policies promoting patient safety and cost-effective blood management solutions are further driving demand.

Mexico is an emerging contributor in the region, supported by improvements in healthcare infrastructure, rising medical tourism, and gradual adoption of advanced surgical technologies. Government initiatives aimed at strengthening hospital capacity are expected to increase adoption of autotransfusion systems in the coming years.

Market Key Players
Key players are Fresenius SE & Co. KGaA, LivaNova PLC, Medtronic, Becton, Dickinson and Company, Zimmer Biomet Holdings, Inc., Haemonetics Corporation, Terumo Corporation, Procell Surgical Inc., and Teleflex Incorporated.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.